ICU Medical, Inc. (ICUI)

ICU Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	46.34	0.73	-117.69	-29.66	-74.29	103.14
Depreciation & Amortization	201.32	200.74	219.51	228.77	235.15	89.7
Stock-Based Compensation	57.59	55.76	46.88	40.56	36.03	27.34
Other Adjustments	31.36	12.66	57.9	62.12	44.71	32.33
Change in Receivables	-37.71	8.88	-46.84	48.64	-19.15	13.76
Changes in Inventories	-11.94	-26.25	16.83	-6.08	-201.1	20.82
Changes in Accounts Payable	-4.95	7	12.53	-68.3	37.47	2.35
Changes in Accrued Expenses	-10.47	-36.97	20.67	-14.48	-55.83	6.26
Changes in Income Taxes Payable	-57.64	-24.76	26.23	-82.36	-66.73	0.87
Changes in Other Operating Activities	-19.37	-17.94	-31.98	-13.02	1.61	-29.01
Operating Cash Flow	167.43	179.85	204.03	166.2	-62.13	267.54
Operating Cash Flow Growth	-20.11%	-11.85%	22.76%	-	-	20.11%
Capital Expenditures	-84.72	-88.04	-79.37	-83.89	-90.31	-68.54
Sale of Property, Plant & Equipment	8.02	8.06	0.75	1.5	0.99	0.22
Purchases of Intangible Assets	-8.65	-8.97	-10.83	-9.78	-9.02	-12.63
Purchases of Investments	-	-	-	-	-3.4	-13.28
Proceeds from Sale of Investments	-	-	0.5	4.22	36.43	18
Payments for Business Acquisitions	-	-	-	-	-1,844	-14.45
Proceeds from Business Divestments	108.45	211.19	-	-	-	-
Investing Cash Flow	127.83	122.23	-88.96	-87.95	-1,909	-90.69
Long-Term Debt Issued	-	-	-	-	1,664	-
Long-Term Debt Repaid	-259.69	-302.75	-51	-29.69	-22.38	-
Net Long-Term Debt Issued (Repaid)	-259.69	-302.75	-51	-29.69	1,642	-
Issuance of Common Stock	5.97	6.11	10.94	4.02	8.79	9.37
Repurchase of Common Stock	-39.15	-8.77	-11.99	-9.35	-10.88	-8.34
Net Common Stock Issued (Repurchased)	-33.18	-2.66	-1.05	-5.33	-2.1	1.04
Other Financing Activities	-2.38	-4.56	-3.75	-0.96	-2.86	-17.91
Financing Cash Flow	-299.31	-311.53	-55.8	-35.98	1,637	-16.87
Effect of Exchange Rate Changes on Cash and Cash Equivalents	2.68	8.85	-4.93	3.16	-9.48	-3.25
Net Cash Flow	-1.37	-0.6	54.34	45.44	-344.04	156.73
Free Cash Flow	82.71	91.8	124.66	82.31	-152.44	199
Free Cash Flow Growth	-9.91%	-26.36%	51.46%	-	-	52.20%
FCF Margin	3.83%	4.11%	5.23%	3.64%	-6.69%	15.12%
Free Cash Flow Per Share	3.33	3.69	5.11	3.42	-6.39	9.14
Levered Free Cash Flow	-198.03	-287.05	15.73	-98.7	1,428	125.58
Unlevered Free Cash Flow	197.8	32.66	261.01	-30.71	-167.59	125.62

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q